share_log

再鼎醫藥:董事會行動通告

ZAI LAB: NOTICE OF BOARD ACTION

HKEX ·  Mar 17 13:04

Summary by Moomoo AI

再鼎醫藥宣佈,董事會將於2025年3月27日(美國東部時間)/3月28日(上海及香港時間)審議及批准2024年度業績及其發佈。公司已於2025年2月27日向美國證交會提交根據美國公認會計準則編製的年度報告。公司表示,即將根據香港上市規則刊發的年度業績將與已向美國證交會提交的業績保持一致,但將額外包含香港上市規則要求的特定資料,以及美國公認會計準則至國際財務報告準則的對賬結果。
再鼎醫藥宣佈,董事會將於2025年3月27日(美國東部時間)/3月28日(上海及香港時間)審議及批准2024年度業績及其發佈。公司已於2025年2月27日向美國證交會提交根據美國公認會計準則編製的年度報告。公司表示,即將根據香港上市規則刊發的年度業績將與已向美國證交會提交的業績保持一致,但將額外包含香港上市規則要求的特定資料,以及美國公認會計準則至國際財務報告準則的對賬結果。
ZAI LAB announced that the Board of Directors will review and approve the performance for the fiscal year 2024 on March 27, 2025 (Eastern Time, USA) / March 28, 2025 (Shanghai and Hong Kong Time). The company submitted its annual report prepared in accordance with US Generally Accepted Accounting Principles to the SEC on February 27, 2025.The company stated that the upcoming annual performance to be published in accordance with Hong Kong listing rules will be consistent with the performance submitted to the SEC, but will additionally include specific information required by Hong Kong listing rules, as well as reconciliation results from US Generally Accepted Accounting Principles to International Financial Reporting Standards.
ZAI LAB announced that the Board of Directors will review and approve the performance for the fiscal year 2024 on March 27, 2025 (Eastern Time, USA) / March 28, 2025 (Shanghai and Hong Kong Time). The company submitted its annual report prepared in accordance with US Generally Accepted Accounting Principles to the SEC on February 27, 2025.The company stated that the upcoming annual performance to be published in accordance with Hong Kong listing rules will be consistent with the performance submitted to the SEC, but will additionally include specific information required by Hong Kong listing rules, as well as reconciliation results from US Generally Accepted Accounting Principles to International Financial Reporting Standards.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 293

Recommended

Statement

This page is machine-translated. Moomoo tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.